This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Flublok® Influenza Vaccine Availability Update: Product To Be Available To Allow Vaccination By Thanksgiving

MERIDEN, Conn., Oct. 10, 2013 /PRNewswire/ -- Protein Sciences Corporation announced today that they expect the first doses of Flublok influenza vaccine for the 2013/2014 season to be released in time for vaccinations to occur prior to Thanksgiving. 

According to the Centers for Disease Control and Prevention (CDC), influenza activity typically peaks in January or later.  It takes about two weeks after vaccination for antibodies to develop in the body that protect against influenza virus infection, so it is best that people get vaccinated before then.

FFF Enterprises is the exclusive distributor of Flublok.  To ensure an adequate supply and timely delivery of Flublok, vaccinators should place their orders with FFF as soon as possible.  Orders can be placed by calling (800) 843-7477 or online at

Manon Cox, President and CEO of Protein Sciences said, "We are pleased to announce the timing of Flublok availability."  She added, "It is important for people to know that the vaccine is coming and will be available in time for people to get protected for the season."

About Protein Sciences and Flublok

Protein Sciences Corporation is a vaccine development and protein production company that is dedicated to saving lives and improving health through the creation of innovative vaccines and biopharmaceu­ticals.  

On January 16, 2013, the U.S. FDA approved Flublok influenza vaccine, coined revolutionary because it is made by making just the active ingredient needed for protection without growing influenza virus.  Flublok is made in a 100% egg-free system using modern cell culture technology.  Flublok is highly pure and does not contain any preservatives (e.g., thimerosal, a mercury derivative), egg proteins, antibiotics or latex.  In addition, it contains 3x the active ingredient in traditional flu vaccines.  The CDC recommends the use of Flublok for all adults 18-49 years old and specifically for those in that age range that have a known or suspected egg allergy, regardless of severity.

Learn more at and

Important Safety Information Flublok is approved for people 18-49 years old to prevent influenza disease. The most common side effect from Flublok is pain at the site of injection. Other side effects may occur and include fatigue, headache and muscle aches.Flublok should not be administered to anyone with a severe allergic reaction (e.g., anaphylaxis) to any vaccine component. Tell the doctor if you have ever experienced Guillain-Barre syndrome (severe muscle weakness) within 6 weeks of receipt of a previous dose of influenza vaccine. If you notice any other problems or symptoms following vaccination, please contact your healthcare professional immediately. Vaccination with Flublok may not protect all individuals. Please see the complete  Package Insert available at or call 203-686-0800 for more information.

SOURCE Protein Sciences Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs